Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | F13A1 | P00488 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30148487 | 1.00 | KMT2A (0.73) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL2964400 | 1.00 | KMT2A (0.73) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL31515175 | 0.98 | KMT2A (0.75) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL22548403 | 0.98 | KMT2A (0.75) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL2962696 | 0.95 | KMT2A (0.79) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL29834154 | 0.95 | KMT2A (0.79) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL591648 | 0.90 | KMT2A (0.91) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL4634469 | 0.90 | KMT2A (0.91) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL8644297 | 0.90 | KMT2A (0.91) | KMT2AMEN1F13A1MAPTRXFP1 | |
| SCHEMBL31672143 | 0.90 | KMT2A (0.91) | KMT2AMEN1F13A1MAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4247968-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | Becton, Dickinson and Company (US) | 2023-09-27 | — | — | EP | claimed |
| WO-2022109339-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220064226-A1 | Panel comprising Borrelia MHC multimers | IMMUDEX APS (DK) | 2022-03-03 | — | — | US | claimed |
| EP-3898666-A2 | PANEL COMPRISING BORRELIA MHC MULTIMERS | Immudex ApS (DK) | 2021-10-27 | — | — | EP | claimed |
| WO-2020127222-A2 | PANEL COMPRISING BORRELIA MHC MULTIMERS | IMMUDEX APS (DK) | 2020-06-25 | — | — | WO | claimed |
| EP-2337795-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | Dako Denmark A/S (DK) | 2011-06-29 | — | — | EP | claimed |
| EP-2254592-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | Dako Denmark A/S (DK) | 2010-12-01 | — | — | EP | claimed |
| EP-2197908-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | Dako Denmark A/S (DK) | 2010-06-23 | — | — | EP | claimed |
| WO-2010037395-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | claimed |
| WO-2010037397-A1 | MHC MULTIMERS IN CMV IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | claimed |
| EP-2167536-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | Dako Denmark A/S (DK) | 2010-03-31 | — | — | EP | claimed |
| EP-2155782-A2 | MHC PEPTIDE COMPLEXES AND USES THEREOF IN INFECTIOUS DISEASES | Dako Denmark A/S (DK) | 2010-02-24 | — | — | EP | claimed |
| WO-2009106073-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | DAKO DENMARK A/S (DK) | 2009-09-03 | — | — | WO | claimed |
| WO-2009039854-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | DAKO DENMARK A/S (DK) | 2009-04-02 | — | — | WO | claimed |
| WO-2009003492-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | DAKO DENMARK A/S (DK) | 2009-01-08 | — | — | WO | claimed |
| WO-2008116468-A2 | MHC PEPTIDE COMPLEXES AND USES THEREOF IN INFECTIOUS DISEASES | DAKO DENMARK A/S (DK) | 2008-10-02 | — | — | WO | claimed |
| WO-2026087501-A1 | ANTIGEN MULTIMERS FOR DETECTION OF ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS | IMMUDEX APS (DK) | 2026-04-30 | — | — | WO | disclosed |
| EP-4709743-A1 | MHC CLASS I MOLECULES | Immudex ApS (DK) | 2026-03-18 | — | — | EP | disclosed |
| WO-2010037402-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010009735-A2 | COMBINATORIAL ANALYSIS AND REPAIR | DAKO DENMARK A/S (DK) | 2010-01-28 | — | — | WO | disclosed |